Jan 10, 2023 / 06:30PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Hello, everyone. I'm Robbie Marcus, the Med Tech Analyst at JPMorgan. Really happy to bring up our next session, Insulet, and I'm going to introduce the CEO, Jim Hollingshead.
We'll do a presentation, then a little Q&A. Jim?
James R. Hollingshead - Insulet Corporation - President, CEO & Director
Robbie, thank you very much. It's great to be here with all of you. Thank you all for coming today.
I want to start with an introduction. On the slide here, you can see Christian. Christian is 6 years old. When he was 3, he was diagnosed with Type 1 diabetes. What he likes to do is he like swimming, he likes hoverboard, and he likes playing with his sisters. And if you look really closely in the photo there, you can see just on the back of his arm, the Omnipod 5. That's the device on the back of his arm. And Christian and his parents love the Omnipod 5, because it allows him to run around and be a kid and play and do all that stuff. It allows him to go to sleep at night
Insulet Corp at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers